Rabeprazole-induced panic attacks

Primary Psychiatry

Volumn 14, Issue 9, 2007, Pages 25-

  Ginsberg, David L ^a  

^a NEW YORK UNIVERSITY MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIDEPRESSANT AGENT; ESOMEPRAZOLE; GASTRIN RELEASING PEPTIDE; PROTON PUMP INHIBITOR; RABEPRAZOLE;

ADULT; ANXIETY; ATTENTION DEFICIT DISORDER; CASE REPORT; CLINICAL FEATURE; CONFUSION; DEPRESSION; DRUG WITHDRAWAL; DUODENITIS; DYSPEPSIA; DYSPNEA; FEAR; FEMALE; GASTRITIS; HEART PALPITATION; HELICOBACTER PULLORUM; HUMAN; MENTAL DISEASE; NIGHTMARE; PANIC; REVIEW; SIDE EFFECT;

EID: 34848881300     PISSN: 10826319     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (9)

1. Aciphex [package insert]. Tokyo: Eisai Co., Ltd; 2003.
2. Polimeni G, Cutroneo P, Gallo A, Gallo S, Spina E, Caputi AP. Rabeprazole and psychiatric symptoms. Ann Pharmacother. 2007;41(7):1315-1317.
3. Williams MP, Sercombe J, Hamilton MI, Pounder RE. A placebo-controlled trial to assess the effects of 8 days of dosing with rabeprazole versus omeprazole on 24-h intragastric acidity and serum gastrin concentrations in young healthy male subjects. Aliment Pharmacol Ther. 1998;12(11):1079- 1089.
4. Warrington S, Baisley K, Boyce M, Tejura B, Morocutti A, Miller N. Effects of rabeprazole, 20 mg, or esomeprazole, 20 mg, on 24-h intragastric pH and serum gastrin in healthy subjects. Aliment Pharmacol Ther. 2002;16(7):1301-1307.
5. Takehara Y, Sumii K, Tari A, et al. Evidence that endogenous GRP in rat stomach mediates omeprazole-induced hypergastrinemia. Am J Physiol. 1996;271(5 Pt 1):G799-804.
6. Roesler R, Henriques JA, Schwartsmann G. Gastrin-releasing peptide receptor as a molecular target for psychiatric and neurologic disorders. CNS Neurol Disord Drug Targets. 2006;5(2):197-204.
7. McCann UD, Slate SO, Geraci M, Uhde TW. Peptides and anxiety: a dose-response evaluation of pentagastrin in healthy volunteers. Anxiety. 1994-1995;1(6):258-267.
8. Geraci M, Anderson TS, Slate-Cothren S, Post RM, McCann UD. Pentagastrin-induced sleep panic attacks: panic in the absence of elevated baseline arousal. Biol Psychiatry. 2002;52(12):1183-1189.
9. Bastaki SM, Hasan MY, Chandranath SI, Schmassmann A, Garner A. PD-136,450: a CCK2 (gastrin) receptor antagonist with antisecretory, anxiolytic and antiulcer activity. Mol Cell Biochem. 2003;252(1-2):83-90.